These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 12369251

  • 1. Erratum to "CNS drugs in Cushing's disease: pathophysiological and therapeutic implications for mood disorders" [Prog. Neuro-Psycol. Biol. Psychiatry, 26, 763 (2002)].
    Sonino N, Fava GA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):1011-8. PubMed ID: 12369251
    [Abstract] [Full Text] [Related]

  • 2. Residual symptoms in depression an emerging therapeutic concept.
    Sonino N, Fava GA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):763-70. PubMed ID: 12188108
    [Abstract] [Full Text] [Related]

  • 3. Drugs in the medical treatment of Cushing's syndrome.
    Schteingart DE.
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
    [Abstract] [Full Text] [Related]

  • 4. Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment.
    Sonino N, Fava GA.
    CNS Drugs; 2001 Dec; 15(5):361-73. PubMed ID: 11475942
    [Abstract] [Full Text] [Related]

  • 5. Psychosomatic aspects of Cushing's disease.
    Sonino N, Fava GA.
    Psychother Psychosom; 1998 Dec; 67(3):140-6. PubMed ID: 9667061
    [Abstract] [Full Text] [Related]

  • 6. Effect of the serotonin antagonists ritanserin and ketanserin in Cushing's disease.
    Sonino N, Fava GA, Fallo F, Franceschetto A, Belluardo P, Boscaro M.
    Pituitary; 2000 Oct; 3(2):55-9. PubMed ID: 11141696
    [Abstract] [Full Text] [Related]

  • 7. Cushing's syndrome.
    Schteingart DE.
    Endocrinol Metab Clin North Am; 1989 Jun; 18(2):311-38. PubMed ID: 2663477
    [Abstract] [Full Text] [Related]

  • 8. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
    Engelhardt D, Weber MM.
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
    [Abstract] [Full Text] [Related]

  • 9. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
    Feelders RA, Hofland LJ, de Herder WW.
    Neuroendocrinology; 2010 Jun; 92 Suppl 1():111-5. PubMed ID: 20829630
    [Abstract] [Full Text] [Related]

  • 10. [ACTH secretion and adrenocortical responsiveness in Cushing's syndrome due to adrenocortical hyperplasia (author's transl)].
    Suzuki S.
    Nihon Naibunpi Gakkai Zasshi; 1976 Aug 20; 52(8):828-44. PubMed ID: 190054
    [Abstract] [Full Text] [Related]

  • 11. Corticotropin-dependent Cushing's syndrome in older people: presentation of five cases and therapeutical use of ketoconazole.
    Berwaerts JJ, Verhelst JA, Verhaert GC, Verhaegen AA, Abs RE.
    J Am Geriatr Soc; 1998 Jul 20; 46(7):880-4. PubMed ID: 9670876
    [Abstract] [Full Text] [Related]

  • 12. [Medical treatment for Cushing's syndrome].
    Nishikawa T, Saito J, Omura M.
    Nihon Rinsho; 2008 Jan 20; 66(1):186-91. PubMed ID: 18186263
    [Abstract] [Full Text] [Related]

  • 13. Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease.
    Sonino N, Fava GA, Belluardo P, Girelli ME, Boscaro M.
    Horm Res; 1993 Jan 20; 39(5-6):202-6. PubMed ID: 8314204
    [Abstract] [Full Text] [Related]

  • 14. Cushing's syndrome: from physiological principles to diagnosis and clinical care.
    Raff H, Carroll T.
    J Physiol; 2015 Feb 01; 593(3):493-506. PubMed ID: 25480800
    [Abstract] [Full Text] [Related]

  • 15. [Clinical usefulness of pharmacological treatment of Cushing's syndrome].
    Saito J, Nishikawa T.
    Nihon Rinsho; 1994 Mar 01; 52(3):793-6. PubMed ID: 8164384
    [Abstract] [Full Text] [Related]

  • 16. [Cushing's syndrome: special issues].
    Goñi Iriarte MJ.
    Endocrinol Nutr; 2009 May 01; 56(5):251-61. PubMed ID: 19627746
    [Abstract] [Full Text] [Related]

  • 17. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.
    Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W.
    N Engl J Med; 1986 May 22; 314(21):1329-35. PubMed ID: 3010108
    [Abstract] [Full Text] [Related]

  • 18. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G.
    Neuro Endocrinol Lett; 2009 Mar 22; 30(1):11-6. PubMed ID: 19300389
    [Abstract] [Full Text] [Related]

  • 19. Pathophysiology of Cushing's disease.
    Fehm HL, Voigt KH.
    Pathobiol Annu; 1979 Mar 22; 9():225-55. PubMed ID: 225710
    [Abstract] [Full Text] [Related]

  • 20. [Diagnosis and differential diagnosis of Cushing's syndrome].
    Penezić Z, Zarković M, Vujović S, Drezgić M.
    Srp Arh Celok Lek; 2006 Mar 22; 134(11-12):558-66. PubMed ID: 17304774
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.